{"id":10753,"date":"2023-06-21T15:08:20","date_gmt":"2023-06-21T12:08:20","guid":{"rendered":"https:\/\/stage.www.cobalt.legal\/?p=10753"},"modified":"2023-06-21T15:09:08","modified_gmt":"2023-06-21T12:09:08","slug":"cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma","status":"publish","type":"post","link":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/","title":{"rendered":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c"},"content":{"rendered":"<p>COBALT atstovavo rizikos kapitalo fond\u0105 \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. \u201ePipelinepharma\u201c pritrauk\u0117 1,3 mln. Eur ir u\u017ebaig\u0117 ankstyvojo etapo investicij\u0173 pritraukimo etap\u0105. Pagrindiniu platformos investuotoju tapo \u201ePractica Capital\u201d, taip pat prisid\u0117jo \u201eIron Wolf Capital\u201c, \u201eBored Pandos\u201c pl\u0117tra u\u017esiimanti UAB \u201ePandos\u201c bei verslo angelai.<\/p>\n<p>\u201ePipelinepharma\u201c yra B2B farmacijos rinka, jungianti vaist\u0173 gamintojus su platintojais visame pasaulyje. Rinka jau sudar\u0117 palankesnes s\u0105lygas farmacijos produkt\u0173 licencijavimui, tiekimui ir \u012fsigijimui, kuri\u0173 vert\u0117 didesn\u0117 nei 200 mln. EUR, apimanti daugiau nei 30 rink\u0173 5 \u017eemynuose.<\/p>\n<p>Investicijos bus skirtos pritraukti geriausius talentus \u012f in\u017einerijos, duomen\u0173 mokslo, farmacijos pardavimo ir rinkodaros komandas, toliau remiantis \u201ePipelinepharma\u201c misija \u2013 padaryti farmacijos produktus prieinamesnius kiekvienam planetos \u017emogui<\/p>\n<p>\u201eEsame tikri, jog absoliuti dauguma farmacijos partnerys\u010di\u0173 ateityje rasis skaitmenin\u0117je erdv\u0117je. Sutrikus tradicini\u0173 verslo parod\u0173 ciklui, pandemija past\u016bm\u0117jo farmacijos verslo vystymui rinktis skaitmenin\u0119 erdv\u0119. Internetin\u0117 prekyviet\u0117 farmacijos bendrov\u0117ms teikia daugyb\u0119 prana\u0161um\u0173. M\u016bs\u0173 sukaupta farmacini\u0173 produkt\u0173 duomen\u0173 baz\u0117 palengvina nauj\u0173 produkt\u0173 atradim\u0105, sistemizuoja deryb\u0173 proces\u0105 bei leid\u017eia suma\u017einti nauj\u0173 produkt\u0173 \u012fvedimo \u012f rink\u0105 s\u0105naudas\u201c, \u2013 sak\u0117 Mindaugas Zagorskis, \u201ePipelinepharma\u201c vadovas.<\/p>\n<p>COBALT konsultavo klient\u0105 sandorio strukt\u016bros klausimais, reng\u0117 sandorio dokumentus, atstovavo \u201ePractica Capital\u201c derybose, atliko teisin\u012f patikrinim\u0105 ir konsultavo kitais su sandoriu susijusiais klausimais. Projekto komandoje \u2013 partner\u0117s, bankininkyst\u0117s ir finans\u0173 praktikos grup\u0117s vadov\u0117s Akvil\u0117 Bosait\u0117 ir Eva Suduiko.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>COBALT atstovavo rizikos kapitalo fond\u0105 \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. \u201ePipelinepharma\u201c pritrauk\u0117 1,3 mln. Eur ir u\u017ebaig\u0117 ankstyvojo etapo investicij\u0173 pritraukimo etap\u0105. Pagrindiniu platformos investuotoju tapo \u201ePractica Capital\u201d, taip pat prisid\u0117jo \u201eIron Wolf Capital\u201c, \u201eBored Pandos\u201c pl\u0117tra u\u017esiimanti..<\/p>\n","protected":false},"author":5,"featured_media":10758,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[29],"country":[92],"class_list":["post-10753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-lt","country-lithuania-lt"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c | COBALT<\/title>\n<meta name=\"description\" content=\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c | COBALT\" \/>\n<meta property=\"og:description\" content=\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/\" \/>\n<meta property=\"og:site_name\" content=\"COBALT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CobaltLegal\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-21T12:08:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-21T12:09:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/06\/thermometer1539191_960_7208600.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1050\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"saturs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"saturs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\u0117\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/\"},\"author\":{\"name\":\"saturs\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/8b9371cd6186321c5b42e891663a4ec0\"},\"headline\":\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c\",\"datePublished\":\"2023-06-21T12:08:20+00:00\",\"dateModified\":\"2023-06-21T12:09:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/\"},\"wordCount\":227,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/thermometer1539191_960_7208600.jpg\",\"articleSection\":[\"Uncategorized @lt\"],\"inLanguage\":\"lt-LT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/\",\"name\":\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c | COBALT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/thermometer1539191_960_7208600.jpg\",\"datePublished\":\"2023-06-21T12:08:20+00:00\",\"dateModified\":\"2023-06-21T12:09:08+00:00\",\"description\":\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. News. Naujienos. Jaunumi. Uudised.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/thermometer1539191_960_7208600.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/thermometer1539191_960_7208600.jpg\",\"width\":1050,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"name\":\"COBALT\",\"description\":\"Top-tier law services in Estonia, Latvia and Lithuania\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\",\"name\":\"COBALT\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"width\":400,\"height\":116,\"caption\":\"COBALT\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CobaltLegal\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/8b9371cd6186321c5b42e891663a4ec0\",\"name\":\"saturs\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/author\\\/saturs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c | COBALT","description":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. News. Naujienos. Jaunumi. Uudised.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/","og_locale":"lt_LT","og_type":"article","og_title":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c | COBALT","og_description":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. News. Naujienos. Jaunumi. Uudised.","og_url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/","og_site_name":"COBALT","article_publisher":"https:\/\/www.facebook.com\/CobaltLegal\/","article_published_time":"2023-06-21T12:08:20+00:00","article_modified_time":"2023-06-21T12:09:08+00:00","og_image":[{"width":1050,"height":700,"url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/06\/thermometer1539191_960_7208600.jpg","type":"image\/jpeg"}],"author":"saturs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"saturs","Est. reading time":"1 minut\u0117"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#article","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/"},"author":{"name":"saturs","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/8b9371cd6186321c5b42e891663a4ec0"},"headline":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c","datePublished":"2023-06-21T12:08:20+00:00","dateModified":"2023-06-21T12:09:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/"},"wordCount":227,"publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/06\/thermometer1539191_960_7208600.jpg","articleSection":["Uncategorized @lt"],"inLanguage":"lt-LT"},{"@type":"WebPage","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/","url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/","name":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c | COBALT","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#primaryimage"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/06\/thermometer1539191_960_7208600.jpg","datePublished":"2023-06-21T12:08:20+00:00","dateModified":"2023-06-21T12:09:08+00:00","description":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c. News. Naujienos. Jaunumi. Uudised.","breadcrumb":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#primaryimage","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/06\/thermometer1539191_960_7208600.jpg","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/06\/thermometer1539191_960_7208600.jpg","width":1050,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-atstovavo-practica-capital-investuojant-i-farmacijos-prekyviete-pipelinepharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cobalt.legal\/lt\/"},{"@type":"ListItem","position":2,"name":"COBALT atstovavo \u201ePractica Capital\u201c investuojant \u012f farmacijos prekyviet\u0119 \u201ePipelinepharma\u201c"}]},{"@type":"WebSite","@id":"https:\/\/www.cobalt.legal\/lt\/#website","url":"https:\/\/www.cobalt.legal\/lt\/","name":"COBALT","description":"Top-tier law services in Estonia, Latvia and Lithuania","publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cobalt.legal\/lt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/www.cobalt.legal\/lt\/#organization","name":"COBALT","url":"https:\/\/www.cobalt.legal\/lt\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","width":400,"height":116,"caption":"COBALT"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CobaltLegal\/"]},{"@type":"Person","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/8b9371cd6186321c5b42e891663a4ec0","name":"saturs","url":"https:\/\/www.cobalt.legal\/lt\/author\/saturs\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/10753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/comments?post=10753"}],"version-history":[{"count":1,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/10753\/revisions"}],"predecessor-version":[{"id":10754,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/10753\/revisions\/10754"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media\/10758"}],"wp:attachment":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media?parent=10753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/categories?post=10753"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/country?post=10753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}